The Contribution of Bone Scintigraphy in benign bone pathology

Illustrations of Cases from the Nuclear Medicine Department at the University Hospital of FES

Authors

  • Assia Seddouki Department of Nuclear Medicine, Hassan II University Hospital Center, Fez, Morocco
  • Dr Sofia Chkikar Department of Nuclear Medicine, Hassan II University Hospital Center, Fez, Morocco
  • Essomada Kpekpeou Department of Nuclear Medicine, Hassan II University Hospital Center, Fez, Morocco
  • Dr Mehdi Goudira Department of Nuclear Medicine, Hassan II University Hospital Center, Fez, Morocco
  • Pr Nadia Imaili Alaoui Department of Nuclear Medicine, Hassan II University Hospital Center, Fez, Morocco

DOI:

https://doi.org/10.59667/sjoranm.v7i1.12

Keywords:

Bone Scintigraphy, Benign bone pathology, hybrid SPECT/CT, topographical diagnosis, quantification and monitoring of bone lesions

Abstract

This work provides an overview of the effectiveness of bone scintigraphy and its role in diagnosing various benign conditions in the Nuclear Medicine Department of the University Hospital of Fez. It analyzes the criteria for selecting scintigraphy as a diagnostic tool and outlines the principles, key features, and protocols involved. These details support clinicians in confirming their diagnostic reasoning when evaluating musculoskeletal lesions or bone abnormalities, guiding their choice of imaging modalities. Clinicians initiate the diagnostic process by identifying relevant clinical factors and areas of uncertainty, leading to a preliminary diagnosis. Subsequently, nuclear physicians tailor the scintigraphy examination to address the specific clinical concerns. It's important to note that the clinical cases presented serve as illustrative examples rather than definitive benchmarks for image quality or equipment settings. They are intended to stimulate individual reflection based on each unique clinical scenario.

Author Biography

  • Assia Seddouki, Department of Nuclear Medicine, Hassan II University Hospital Center, Fez, Morocco

    Dr Assia Seddouki , nuclear medicine department at FES University Hospital (Morroco)

References

- M. Dumont *, C. Côté : La scintigraphie osseuse en trois phases pancorporelles, novembre 2012, ELSEVIER MASSON

- P. Granier *, M. Mourad : Exploration des polyalgies par la scintigraphie osseuse planaire couplée à la TEMP-TDM, octobre 2010, ELSEVIER MASSON

- Parisi MT, Otjen JP, Stanescu AL, et al. Radionuclide imaging of infection and inflammation in children: a review. Semin Nucl Med 2018 ; 48:148–65.

- Frédéric Paycha, Société française de médecine nucléaire et imagerie moléculaire (SFMN), Guide pour la rédaction de protocole pour la scintigraphie osseuse, Médecine Nucléaire 36 (2012) 687-697.

- A. Matrane , A. Guensi , M. Kebbou, Histiocytose langerhansienne osseuse multifocale : intérêt de la scintigraphie osseuse planaire, Médecine Nucléaire 36 (2012) 730-735

- https://www.universalis.fr/encyclopedie/technetium/2-technetium-et-imagerie-medicale/

- Guide du don usage de l’amylose cardique de L'ASNC et de L'EANM

- Résumé des caractéristiques du produit ANSM - Mis à jour le : 02/07/2008

SPECT-CT of pelvis

Downloads

Published

2024-04-14

Issue

Section

Research Articles

How to Cite

The Contribution of Bone Scintigraphy in benign bone pathology: Illustrations of Cases from the Nuclear Medicine Department at the University Hospital of FES. (2024). Swiss Journal of Radiology and Nuclear Medicine, 7(1), 12. https://doi.org/10.59667/sjoranm.v7i1.12

Similar Articles

11-20 of 24

You may also start an advanced similarity search for this article.